Nuvation Bio Inc.
NUVB
$4.39
-$0.11-2.44%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.99% | -35.38% | 87.24% | -259.90% | -258.63% |
| Total Depreciation and Amortization | 146.12% | 229.63% | 45.90% | 434.48% | 298.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.87% | 114.57% | -97.62% | 107.09% | 6,615.28% |
| Change in Net Operating Assets | 6.98% | -274.12% | 103.17% | 159.86% | -368.15% |
| Cash from Operations | 35.78% | -70.14% | -29.08% | -171.47% | -208.08% |
| Capital Expenditure | -784.62% | 91.89% | -- | -166.67% | 200.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 68.12% | -430.13% | 153.10% | 616.79% | 56.36% |
| Cash from Investing | 68.20% | -431.85% | 60.11% | 618.40% | 56.11% |
| Total Debt Issued | 100.95% | -- | 2,727.31% | -- | -- |
| Total Debt Repaid | -52.29% | 97.88% | 97.37% | -- | -- |
| Issuance of Common Stock | 632.18% | -66.59% | -36.36% | 5,052.38% | 865.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 995.89% | 132.57% | 6,938.68% | 2,509.52% | -850.00% |
| Foreign Exchange rate Adjustments | -120.05% | 91.37% | -264.10% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,046.28% | -3,408.43% | 88,985.78% | 250.56% | -68.85% |